Feed TTOO
TT

T2 Biosystems, Inc.

TTOO · OTC

$0.00 +0.00% (+$0.00)
1M -80.00%
Market Cap $16.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.00x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining
Rev. growth 26.52%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak
Gross margin 113.58%
Net margin 696.19%
FCF margin 671.88%
Quality
4 /100
Poor
ROIC 230.51%
ROA 143.91%
Asset turnover 0.21x
Debt
1 /100
High
Current ratio 0.45x
Int. coverage -8.37x
Debt/Equity N/A
Stability
14 /100
Unstable
Beta 7.95x
Rev. volatility 61.79%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o TTOO
Online

O podjetju

T2 Biosystems, Inc. is an American biotechnology company that specializes in the diagnosis of infectious diseases. It utilizes a technology called T2 Magnetic Resonance (T2MR), which combines magnetic resonance with nanoparticles for the detection of pathogens in biological samples. T2 Biosystems focuses on innovative diagnostic solutions aimed at accelerating the process of infection diagnosis and improving patient care. Shares of T2 Biosystems, Inc. are traded on the stock exchange and may be an interesting investment opportunity for those following developments in biotechnology and diagnostics.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Craig R. Jalbert

Employees

113

Headquarters

Lexington

Prihajajoči dogodki

13 NOV.

Earnings

Upcoming earnings report

52d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.